Amy Farris Wolfe

Amy Farris Wolfe serves as General Counsel at Aurobindo Pharma USA, Inc. since 2020, leading the US Legal Department and overseeing significant transactions, including the acquisition of Mylan LLC and the divestiture of Natrol LLC for $560 million. Previously, Amy held roles as Assistant General Counsel, where oncology products were launched during the COVID-19 pandemic, and as Commercial Counsel at Parexel, drafting contracts for global clients. Experience includes legal practice at Duane Morris LLP as an Associate specializing in technology transactions and as a Summer Associate, alongside a Summer Law Clerk position at Ortoli | Rosenstadt LLP. Academic credentials include a Juris Doctor from American University Washington College of Law, with additional studies in International Business Transactions and courses in International Criminal Law and Legal Approaches to Terrorism. An undergraduate degree in Philosophy and Visual Anthropology was earned at Temple University.